Active cerebellum rTMS for Schizophrenia
This trial will use transcranial magnetic stimulation (TMS) to study how hallucinations work in schizophrenia and whether or not the magnetic field can improve symptoms.
- Schizoaffective Disorder
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many individuals have thus far enlisted in this clinical investigation?
"Affirmative. Clinicaltrials.gov shows that the trial, which was initially published on October 13th 2021, is actively searching for participants. 68 individuals must be recruited from 1 medical facility in order to proceed with this research study."
Is there still an opportunity to join this medical experiment?
"Data found on clinicaltrials.gov shows that this research study is still searching for participants; the posting was initially made on October 13th 2021 and revised most recently on August 10th 2022."
Who is eligible to participate in this medical research?
"This research project is seeking 68 participants, aged between 18 and 55 years old with a diagnosis of schizophrenia or schizoaffective disorder."
Is there an age cap for applicants to this research project?
"Patients that meet the age criteria of 18 and below 55 years old can join this medical trial."